Skip to Content

Nanowires in the Brain

Making brain implants safer, cheaper.

To treat severe cases of Parkinson’s disease, surgeons implant electrodes deep in the brain, where they deliver high-frequency electrical pulses that shut down neural systems responsible for the disease’s characteristic tremors. But this expensive treatment, called deep brain stimulation, is risky: the patient’s skull must be opened, and the electrodes can damage blood vessels in the brain.

NYU’s electrode (represented in red) fits through tiny capillaries. (Courtesy of Rodolfo Llinas)

A new type of polymer nanoelectrode, however, could make brain implants far safer and less costly. Rodolfo Llinas, a professor of neuroscience at New York University, has worked with Ian Hunter, a professor of mechanical and biological engineering at MIT, to develop a nano-wire electrode just 600 nanometers across – so thin that it could be inserted through an artery in the arm or groin, threaded up to the brain, and snaked through the smallest blood vessels, getting close enough to neurons to detect and deliver electrical signals.

Before the technology can be used in humans, the researchers will have to demonstrate that the nanowires do not cause complications, such as blood clots. But Joseph Pancrazio, a program director at the National Institute of Neurological Disorders and Stroke, says, “There may be payoffs in terms of safety, efficacy, robustness, and biocompatibility….This is a completely out-of-the-box way to think about enabling deep brain stimulation.”

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.